These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36315906)

  • 1. Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count.
    Coupet CA; Dubois C; Evlachev A; Kehrer N; Baldazza M; Hofman S; Vierboom M; Martin P; Inchauspe G
    Hum Vaccin Immunother; 2022 Nov; 18(6):2133914. PubMed ID: 36315906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models.
    Lélu K; Dubois C; Evlachev A; Crausaz M; Baldazza M; Kehrer N; Brandely R; Schlesinger Y; Silvestre N; Marchand JB; Bastien B; Leung-Theung-Long S; Unsinger J; Martin P; Inchauspé G
    J Immunol; 2022 Jul; 209(1):99-117. PubMed ID: 35667841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel virotherapy encoding human interleukin-7 improves
    Crausaz M; Monneret G; Conti F; Lukaszewicz AC; Marchand JB; Martin P; Inchauspé G; Venet F
    Front Immunol; 2022; 13():939899. PubMed ID: 36045686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates.
    Fry TJ; Moniuszko M; Creekmore S; Donohue SJ; Douek DC; Giardina S; Hecht TT; Hill BJ; Komschlies K; Tomaszewski J; Franchini G; Mackall CL
    Blood; 2003 Mar; 101(6):2294-9. PubMed ID: 12411295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
    García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
    J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells.
    Zimmerling S; Waibler Z; Resch T; Sutter G; Schwantes A
    Virol J; 2013 Jan; 10():34. PubMed ID: 23356675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model.
    Remy-Ziller C; Thioudellet C; Hortelano J; Gantzer M; Nourtier V; Claudepierre MC; Sansas B; Préville X; Bendjama K; Quemeneur E; Rittner K
    Hum Vaccin Immunother; 2018 Jan; 14(1):140-145. PubMed ID: 28925793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
    Shen X; Basu R; Sawant S; Beaumont D; Kwa SF; LaBranche C; Seaton KE; Yates NL; Montefiori DC; Ferrari G; Wyatt LS; Moss B; Alam SM; Haynes BF; Tomaras GD; Robinson HL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
    Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
    Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory.
    Hinterberger M; Giessel R; Fiore G; Graebnitz F; Bathke B; Wennier S; Chaplin P; Melero I; Suter M; Lauterbach H; Berraondo P; Hochrein H; Medina-Echeverz J
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579736
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates.
    Millington T; Koulmanda M; Ng C; Boskovic S; Nadazdin OM; Benichou G; Zheng XX; Strom TB; Madsen JC
    J Heart Lung Transplant; 2012 Apr; 31(4):427-35. PubMed ID: 22366291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
    J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
    Staib C; Kisling S; Erfle V; Sutter G
    J Gen Virol; 2005 Jul; 86(Pt 7):1997-2006. PubMed ID: 15958679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors.
    Tenesaca S; Vasquez M; Alvarez M; Otano I; Fernandez-Sendin M; Di Trani CA; Ardaiz N; Gomar C; Bella A; Aranda F; Medina-Echeverz J; Melero I; Berraondo P
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.
    Garber DA; O'Mara LA; Gangadhara S; McQuoid M; Zhang X; Zheng R; Gill K; Verma M; Yu T; Johnson B; Li B; Derdeyn CA; Ibegbu C; Altman JD; Hunter E; Feinberg MB
    J Virol; 2012 Dec; 86(23):12605-15. PubMed ID: 22973033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.